CoChat
Sign Up
Cited by 581

The DOI matches its Crossref record.

Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene

Shultz, Leonard D., Schweitzer, Peter A., Rajan, T.V., Yi, Taolin, Ihle, James N., Matthews, R. James, Thomas, Matthew L., Beier, David R.·1993·Cell
DOI 10.1016/0092-8674(93)90369-2
Open this paper in CoChat — free account

Abstract

Mice homozygous for the recessive allelic mutation motheaten (me) or viable motheaten (mev) on chromosome 6 develop severe defects in hematopoiesis. In this paper we present the findings that the me and mev mutations are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. High resolution mapping localized me to an area tightly linked to Hcph on chromosome 6. Abnormalities of the Hcph protein product were demonstrated by Western blot analysis and by activity assays in both me/me and mev/mev mice. Molecular analysis of the Hcph cDNA identified abnormal transcripts in both mutants. DNA sequence analyses of cDNA and genomic clones revealed that both the me and mev mutations are point mutations that result in aberrant splicing of the Hcph transcript. These findings provide the first available animal models for a specific protein-tyrosine phosphatase deficiency, thus facilitating determination of the precise role of this signaling molecule in hematopoiesis.

Overview

Integrity signals

Registry

Crossref · 10.1016/0092-8674(93)90369-2

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 61

  1. Armstrong, 1985, Retroviral infection of accessory cells and the immunological paradox in AIDS, Immunol. Today, 6, 121, 10.1016/0167-5699(85)90076-3 · DOI
  2. Blom, 1976, A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy, Acta Pathol. Microbiol. Scand. (A), 84, 335
  3. Bolen, 1992, The Src family of tyrosine protein kinases in hemopoietic signal transduction, FASEB J., 6, 3403, 10.1096/fasebj.6.15.1281458 · DOI
  4. Brown-Shimer, 1992, Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene, Cancer Res., 52, 478
  5. Cahilly, 1985, Regional mapping of cKi-ras proto-oncogene on mouse chromosome 6 by in situ hybridization, Cytogenet. Cell Genet., 39, 140, 10.1159/000132123 · DOI
  6. Cantley, 1991, Oncogenes and signal transduction, Cell, 64, 281, 10.1016/0092-8674(91)90639-G · DOI
  7. Carroll, 1987, tdic(9; 12): a nonrandom chromosome abnormality in childhood B cell precursor acute lymphoblastic leukemia: a pediatric oncology group study, Blood, 70, 1962, 10.1182/blood.V70.6.1962.1962 · DOI
  8. Chomczynski, 1987, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 · DOI
  9. Clark, 1981, Mutations in mice that influence natural killer (NK) cell activity, Immunogenetics, 12, 601, 10.1007/BF01561700 · DOI
  10. Davidson, 1979, Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes, J. Immunol., 122, 884, 10.4049/jimmunol.122.3.884 · DOI
  11. Dietrich, 1992, A genetic map of the mouse suitable for typing intraspecific crosses, Genetics, 131, 423, 10.1093/genetics/131.2.423 · DOI
  12. Druker, 1989, Oncogenes, growth factors, and signal transduction, N. Engl. J. Med., 321, 1383, 10.1056/NEJM198911163212007 · DOI
  13. Feng, 1993, SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases, Science, 259, 1607, 10.1126/science.8096088 · DOI
  14. Freitas, 1990, VH gene family repertoires of viable motheaten mice, Eur. J. Immunol., 20, 1033, 10.1002/eji.1830200513 · DOI
  15. Gebbers, 1976, Plasma cell alterations in ulcerative colitis, Pathol. Eur., 11, 271
  16. Green, 1975, Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology, J. Hered., 66, 250, 10.1093/oxfordjournals.jhered.a108625 · DOI
  17. Hanahan, 1983, Studies on transformation of Escherichia coli with plasmids, J. Mol. Biol., 166, 557, 10.1016/S0022-2836(83)80284-8 · DOI
  18. Hayashi, 1988, Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice, J. Immunol., 140, 2139, 10.4049/jimmunol.140.7.2139 · DOI
  19. Herzenberg, 1986, The Ly-1 B cell lineage, Immunol. Rev., 93, 81, 10.1111/j.1600-065X.1986.tb01503.x · DOI
  20. Kantor, 1991, The development and repertoire of B-1 cells (CD5 B cells), Immunol. Today, 12, 389, 10.1016/0167-5699(91)90136-H · DOI
  21. Kasturi, 1990, Germline V genes encode viable motheaten mouse auto-antibodies against thymocytes and red blood cells, J. Immunol., 145, 2304, 10.4049/jimmunol.145.7.2304 · DOI
  22. Koch, 1991, SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins, Science, 252, 668, 10.1126/science.1708916 · DOI
  23. Koff, 1993, Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β, Science, 260, 536, 10.1126/science.8475385 · DOI
  24. Kolber, 1991, Phorbol ester responsiveness of murine Ly-1-lineage B cells from normal and viable motheaten mutant mice, Eur. J. Immunol., 21, 721, 10.1002/eji.1830210327 · DOI
  25. Komschlies, 1987, Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer, J. Exp. Med., 166, 1162, 10.1084/jem.166.4.1162 · DOI
  26. Koo, 1991, Suppressive effects of monocytic cells and transforming growth factor-β on natural killer cell differentiation in autoimmune viable motheaten mutant mice, J. Immunol., 147, 1194, 10.4049/jimmunol.147.4.1194 · DOI
  27. Laiho, 1990, Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation, Cell, 62, 175, 10.1016/0092-8674(90)90251-9 · DOI · Paper page
  28. Matthews, 1992, Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences, Mol. Cell. Biol., 12, 2396
  29. Medlock, 1987, Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a micro-environmental defect for the generation of terminal deoxynucleotidyl-transferase-positive bone marrow cells in vitro, J. Immunol., 138, 3590, 10.4049/jimmunol.138.11.3590 · DOI
  30. Miller, 1966, Familial reticuloendotheliosis: cocurrence of disease in five siblings, Pediatrics, 38, 986, 10.1542/peds.38.6.986 · DOI
  31. Miura, 1991, Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis, Mol. Cell. Biol., 11, 4895
  32. Morris, 1993, Protein tyrosine phosphorylation through the slgM receptor of B-1 lymphocytes, J. Immunol., 150, 262A
  33. Painter, 1988, Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice, J. Exp. Med., 167, 1137, 10.1084/jem.167.3.1137 · DOI
  34. Perlmutter, 1993, Regulation of lymphocyte function by protein phosphorylation, Annu. Rev. Immunol., 11, 451, 10.1146/annurev.iy.11.040193.002315 · DOI
  35. Plutzky, 1992, Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6), Genomics, 13, 869, 10.1016/0888-7543(92)90172-O · DOI
  36. Raimondi, 1986, Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia, Blood, 68, 69, 10.1182/blood.V68.1.69.69 · DOI
  37. Raimondi, 1991, New recurring chromosomal translocations in childhood acute lymphoblastic leukemia, Blood, 77, 2016, 10.1182/blood.V77.9.2016.2016 · DOI
  38. Rettenmier, 1985, The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity, Science, 228, 320, 10.1126/science.2580348 · DOI
  39. Schweitzer, 1991, Synthesis of abnormal immunoglobulins by hybridomas from autoimmune “viable motheaten” mutant mice, J. Cell Biol., 114, 35, 10.1083/jcb.114.1.35 · DOI
  40. Shen, 1991, A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases, Nature, 352, 736, 10.1038/352736a0 · DOI · Paper page
  41. Sherr, 1985, The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1, Cell, 41, 665, 10.1016/S0092-8674(85)80047-7 · DOI
  42. Shultz, 1988, Pleiotropic effects of deleterious alleles at the “motheaten” locus, Curr. Top. Microbiol. Immunol., 137, 216
  43. Shultz, 1991, Hematopoiesis and models of immunodeficiency, Sem. Immunol., 3, 397
  44. Shultz, 1991, Immunological mutants of the mouse, Am. J. Anat., 191, 303, 10.1002/aja.1001910310 · DOI
  45. Shultz, 1976, Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins, J. Immunol., 116, 936, 10.4049/jimmunol.116.4.936 · DOI
  46. Shultz, 1987, Genetically determined murine models of immunodeficiency, Annu. Rev. Immunol., 5, 367, 10.1146/annurev.iy.05.040187.002055 · DOI
  47. Shultz, 1983, Hematopoietic stem cell function in motheaten mice, Exp. Hematol., 11, 667
  48. Shultz, 1984, “Viable motheaten”: a new allele at the motheaten locus. I. Pathology, Am. J. Pathol., 116, 179
  49. Shultz, 1987, Development of plasmacytoid cells with Russell bodies in autoimmune “viable motheaten” mice, Am. J. Pathol., 127, 38
  50. Sidman, 1978, The mouse mutant “motheaten.” I. Development of lymphocyte populations, J. Immunol., 121, 2392, 10.4049/jimmunol.121.6.2392 · DOI
  51. Sidman, 1986, Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice, Science, 232, 1423, 10.1126/science.3487115 · DOI
  52. Spivak, 1992, Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction, Exp. Hematol., 20, 500
  53. Tsukada, 1993, Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia, Cell, 72, 279, 10.1016/0092-8674(93)90667-F · DOI
  54. Van Zant, 1989, Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev), Exp. Hematol., 17, 81
  55. Vogel, 1993, Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation, Science, 259, 1611, 10.1126/science.7681217 · DOI
  56. Yeung, 1992, Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1, J. Biol. Chem., 267, 23447, 10.1016/S0021-9258(18)35855-1 · DOI
  57. Yi, 1993, Association of hematopoietic cell phosphatase (HCP) with c-Kit following stimulation with c-kit ligand, Mol. Cell. Biol., 13, 3350
  58. Yi, 1991, Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification, Blood, 78, 2222, 10.1182/blood.V78.9.2222.2222 · DOI
  59. Yi, 1992, Assignment of a novel protein tyrosine phosphatase gene (hcph) to mouse chromosome 6, Genomics, 14, 793, 10.1016/S0888-7543(05)80189-2 · DOI
  60. Yi, 1992, Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12–p13, Mol. Cell. Biol., 12, 836
  61. Zhao, 1993, Purification and characterization of a protein tyrosine phosphatase containing SH2 domains, J. Biol. Chem., 268, 2816, 10.1016/S0021-9258(18)53846-1 · DOI

Cited by

Sorted by citations

See all 581

Metadata

Authors
Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., & Beier, D. R.
Venue
Cell
Publisher
Elsevier BV
Published
1993-07
Volume
73
Issue
7
Pages
1445-1454
ISSN
0092-8674
DOI
10.1016/0092-8674(93)90369-2
Cited by
581
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review